Hematologic Neoplasms - 25 Studies Found Recruiting : Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors : Hematologic Neoplasms : 2011-06-15 : Drug: Cyclophosphamide 14.5 mg Not yet recruiting : Prophylactic Early PN in HPT/BMT : Hematologic Neoplasms : 2017-03-08 : Dietary Supplement: Parenteral nutrition. Recruiting : A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy : Hematologic Neoplasms : 2016-09-06 : Drug: Itraconazole Participant Recruiting : Platelet Transfusion Requirements in Hematopoietic Transplantation : Hematologic Neoplasms : 2016-01-06 : Drug: Tranexamic Acid Recruiting : Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients : Hematologic Neoplasms : 2015-11-30 : Procedure: Allogeneic (Allo) hematopoietic stem cell transplantation Recruiting : Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood Units : Hematologic Neoplasms : 2015-07-17 : Procedure: T-Cell replete haplo-transplant Infusion of haploidentical related donor peripheral blood ste Recruiting : Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant : Hematologic Neoplasms : 2015-05-18 : Biological: BPX-501 Biological Recruiting : Safety Study of Anti-LAG-3 in Relapsed or Refractory Hematologic Malignancies : Hematologic Neoplasms : 2014-02-12 : Biological: BMS-986016 Other N Active, not recruiting : Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation : Hematologic Neoplasms : 2013-07-31 : Drug: AG-221 AG-221 administered orally on every day of 28 day cycles until disease progression or unacc Active, not recruiting : Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy : Hematologic Neoplasms : 2013-05-28 <<< Previous | Next >>>
